A neurosurgeon and a neuroscientist discover promising new ways to help people with spinal cord injuries walk again ...
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic ...
Mission Viejo's neurosurgeon explores spinal cord stimulation as a promising alternative for chronic back pain relief, ...
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/2.3cY8rBmp.js ...
Lineage Cell Therapeutics initiates DOSED clinical study of OPC1 for spinal cord injury: Carlsbad, California Thursday, February 13, 2025, 14:00 Hrs [IST] Lineage Cell Therapeutic ...
Sylvie Hudon was admitted to the hospital, she says nurses visiting her home told her not to worry about the bedsore located ...
Lineage Cell Therapeutics (LCTX) announced that the Company has initiated the DOSED clinical study. The DOSED study will evaluate the safety ...
A new robotic glove developed at Oshawa’s Ontario Tech University is helping stroke and spinal cord injury patients regain ...
Spinal cord injury (SCI) remains the most serious complication of repairing descending thoracic and thoracoabdominal aortic aneurysms, with endovascular ...
Mission Viejo's neurosurgeon explores spinal cord stimulation as a promising alternative for chronic back pain relief, focusing on innovative treatments. MISSION VIEJO, CALIFORNIA / ACCESS Newswire / ...
Neurosurgeon Jocelyne Bloch, MD, and neuroscientist Grégoire Courtine, PhD, co-direct their lab, NeuroRestore, and are working to use artificial intelligence-driven implants to help spinal cord injury ...
Neuvotion announced today that it received FDA 510(k) clearance for its first product, the NeuStim wearable device.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback